Brazilian National Institute of Industrial Property Rejects Truvada® Patent Application
On 24 January 2017, Brazil’s National Institute of Industrial Property (INPI) made public a decision to reject the patent application...
Open Letter to WHO Director General, Margaret Chan
Civil Society Open Letter urging WHO to include UN High Level Panel on Access to Medicines Report on WHO Board Agenda
Thai Activists and Hospital Staff Review Progress on HCV Treatment
Community groups and government hospital staff from eight provinces met to review access to medicines on 15 and 16 November. The...
Seminar: Policies around Access to Medicines & Human Rights
Watch the presentations of the "Sustainability, Health Systems and Human Rights" at the Seminar on Policies of Access to Medicines and Human Rights.
Price of HIV Drug Atripla Set to Drop
Almost 3000 more people living with HIV set to get life-saving treatment in Ukraine.
Want to Improve Access to ARVs?
Sign up for your chance to learn how to challenge intellectual property barriers, that impede access to affordable medicines.
High price of lopinavir/ritonavir challenged in Ukraine
All-Ukrainian PLHIV Network challenges patent, and exclusive right to manufacture lopinavir/ritonavir.
A generic version of dolutegravir will be made available in Morocco: A major victory for ITPC-MENA
After several months of intense advocacy by treatment activists, ViiV Healthcare has extended its dolutegravir license to Morocco, meaning more...
Thai civil society oppose proposal to amend patent law
New law could undermine access to drugs Thai civic groups expressed their grave concerns over the patent law amendment proposed by...
Defending Argentina’s public health from unmerited patents
Fundación Grupo Efecto Positivo defends Argentina’s public health from the abusive patents by multinational pharmaceutical companies Fundación Grupo Efecto Positivo...